P48.04 IMfirst; Phase IIIB Safety Study of Atezolizumab Plus Chemotherapy in a Real World Population of Untreated ES-SCLC

Authors :: M. Domine Gomez
A. Moreno Vega
M. Cobo Dols
R. Garcia Campelo
L. Crama
E. Arriola Aperribay
P. Ruiz Gracia
M. Majem Tarruella
J. De Castro Carpeno
Source :: Journal of Thoracic Oncology. 16:S500-S501
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Chemotherapy
business.industry
Atezolizumab
medicine.medical_treatment
Internal medicine
Medicine
business

Tools